BRIACELL THERAPEUTICS CORP. Number Of Share Options Granted In Share-based Payment Arrangement
BRIACELL THERAPEUTICS CORP. (BCTX) reported Number Of Share Options Granted In Share-based Payment Arrangement of 787.30 thousand shares for the 9-month period ending 2022-04-30, per its 6-K filed 2022-06-13.
Discontinued › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement · last filed 2022-06-13
- BRIACELL THERAPEUTICS CORP. number of share options granted in share-based payment arrangement for the quarter ending 2022-04-30 was 150.00K shares.
| Period end | Number Of Share Options Granted In Share-based Payment Arrangement 3 month | Number Of Share Options Granted In Share-based Payment Arrangement 6 month | Number Of Share Options Granted In Share-based Payment Arrangement 9 month | Number Of Share Options Granted In Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2022-04-30 | 150.00K shares derived: 6-K 9 month − 6-K 6 month · filed 2022-06-13 | 787.30K shares 6-K · filed 2022-06-13 | ||
| 2022-01-31 | 637.30K shares 6-K · filed 2022-03-15 | |||
| 2021-07-31 | 672.00K shares 6-K · filed 2022-06-13 | |||
| 2020-07-31 | 166.00 shares 40-F/A · filed 2021-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |